Psychedelic drug developers are undeterred by the FDA’s Complete Response Letter for Lykos’ MDMA therapy for PTSD, and experts expect the company will ultimately obtain approval.
Tag Archive for: psychedelic drug
The U.S. health regulator’s staff reviewers raised concerns related to interpretation of results from trials for Lykos Therapeutics psychedelic drug MDMA to treat post-traumatic stress disorder.